Dahlbeck Scott 4
4 · Kiromic Biopharma, Inc. · Filed May 25, 2022
Insider Transaction Report
Form 4
Dahlbeck Scott
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-05-23+17,240→ 446,757 total - Exercise/Conversion
Restricted Stock Units
2022-05-23−17,240→ 0 total→ Common Stock (17,240 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On August 20, 2020, the reporting person was granted 17,420 restricted stock units, vesting on October 16, 2021.